Piet Swart

Novartis (Switzerland)

Papers

1

Total Citations

5

H-Index

1

About

Piet Swart is a specialist in drug metabolism and radiochemical analysis, whose work has advanced the critical field of metabolite identification in pharmaceutical development. His key research areas include low-level radioactivity measurement, biotransformation pathway elucidation, and the development of automated platforms for metabolite profiling. Swart’s major contribution is the design of a unique automation platform that enables precise detection of ¹⁴C- and ³H-labeled compounds, allowing researchers to identify physiologically relevant metabolites and define metabolic pathways with unprecedented accuracy. This innovation directly addresses the growing need for reliable metabolite identification in drug development, where understanding a compound’s metabolic fate is essential for safety and efficacy assessments. His most-cited work (5 citations) provides a foundational methodology for generating and interpreting biotransformation data, making it a valuable resource for scientists in pharmacokinetics and toxicology. Swart’s achievements underscore his role in bridging analytical chemistry and drug discovery, offering tools that streamline the complex process of metabolite structure elucidation. For students and researchers, his work exemplifies how technical innovation can solve practical challenges in pharmaceutical research, ensuring that drugs are both safe and effective before reaching clinical trials.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
A Unique Automation Platform for Measuring Low Level Radioactivity in Metabolite Identification Studies
5 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago